Back to Search Start Over

Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patients.

Authors :
Holzer, Marie-Therese
Almanzar, Giovanni
Woidich, Robert
Hügle, Boris
Haas, Johannes-Peter
Prelog, Martina
Source :
Pediatric Rheumatology; 7/19/2022, Vol. 20 Issue 1, p1-7, 7p
Publication Year :
2022

Abstract

Background: The plasticity of T helper-17 (Th17) and regulatory T (Treg) cells may be a clue to pathogenesis of Juvenile Idiopathic Arthritis (JIA). It is still unclear, whether targeted suppression of Interleukin (IL)-17 is able to influence regulatory function of Treg to control pro-inflammatory effectors in JIA. This study aimed to assess the effect of a Th17-stimulating cytokine environment and of IL-17A-inhibition on phenotype plasticity and suppressive function of Treg derived from JIA patients. Methods: Th17 and Treg characteristics of CD4<superscript>+</superscript> helper T cells were investigated in blood samples of JIA patients with oligo- and polyarticular pattern and healthy controls (HC). Isolated CD4<superscript>+</superscript>CD25<superscript>+</superscript>CD127<superscript>−</superscript> cells defined as Treg were cultivated with Th17-inducing cytokine environment as well as with IL-17A-inhibitors and analyzed for plasticity of phenotype by flow cytometry. Furthermore, inhibitory function of Treg on autologous effectors after cultivation with these stimuli was determined by suppression assays. Results: Our findings demonstrated significantly elevated proportions of Th17 and Th17-like Treg in JIA compared to HC. After incubation with Th17-inducing stimuli, increased FoxP3 expression in separated Treg in JIA and an impaired suppressive capacity in JIA and HC were found. Blockade of IL-17A resulted in adjustment of FoxP3-expression in JIA to proportions found in controls and in regular suppressive function. Conclusions: Our results demonstrate an induction of FoxP3 expressing Treg by Th17-inducing cytokines with concomitant mitigated suppressive function. In contrast, specific IL-17A blockade maintains suppressive Treg function and adjusted FoxP3-expression in JIA to levels found in controls. These findings may help to provide experimental evidence for the successful clinical use of IL-17A inhibition in JIA patients. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15460096
Volume :
20
Issue :
1
Database :
Complementary Index
Journal :
Pediatric Rheumatology
Publication Type :
Academic Journal
Accession number :
158080165
Full Text :
https://doi.org/10.1186/s12969-022-00680-z